{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:17Z","timestamp":1780617617271,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03071-9","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:58:06Z","timestamp":1738954686000},"page":"433-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hydrogen sulphide alleviates platelet dysfunction in patients with type 2 diabetes"],"prefix":"10.1007","volume":"58","author":[{"given":"Minqi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxue","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"3071_CR1","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, Zhang X, Li C, Huang Z, Sun X, Wang L, Zhou M, Wu J, Wang Y (2021) Prevalence and treatment of diabetes in China, 2013\u20132018. JAMA 326:2498\u20132506. https:\/\/doi.org\/10.1001\/jama.2021.22208","journal-title":"JAMA"},{"key":"3071_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1538-7836.2011.04217.x","volume":"9","author":"B Nagy","year":"2011","unstructured":"Nagy B, Jin J, Ashby B, Reilly MP, Kunapuli SP (2011) Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J Thromb Haemost 9:810\u2013819. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04217.x","journal-title":"J Thromb Haemost"},{"key":"3071_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/jth.14788","volume":"18","author":"S Handtke","year":"2020","unstructured":"Handtke S, Thiele T (2020) Large and small platelets-(When) do they differ? J Thromb Haemost 18:1256\u20131267. https:\/\/doi.org\/10.1111\/jth.14788","journal-title":"J Thromb Haemost"},{"key":"3071_CR4","doi-asserted-by":"publisher","first-page":"154838","DOI":"10.1016\/j.metabol.2021.154838","volume":"123","author":"J-S Yun","year":"2021","unstructured":"Yun J-S, Ko S-H (2021) Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism 123:154838. https:\/\/doi.org\/10.1016\/j.metabol.2021.154838","journal-title":"Metabolism"},{"key":"3071_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12933-021-01267-w","volume":"20","author":"A Giannella","year":"2021","unstructured":"Giannella A, Ceolotto G, Radu CM, Cattelan A, Iori E, Benetti A, Fabris F, Simioni P, Avogaro A, Vigili de Kreutzenberg S (2021) PAR-4\/Ca-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. Cardiovasc Diabetol 20:77. https:\/\/doi.org\/10.1186\/s12933-021-01267-w","journal-title":"Cardiovasc Diabetol"},{"key":"3071_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1152\/physrev.00028.2021","volume":"103","author":"G Cirino","year":"2023","unstructured":"Cirino G, Szabo C, Papapetropoulos A (2023) Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiol Rev 103:31\u2013276. https:\/\/doi.org\/10.1152\/physrev.00028.2021","journal-title":"Physiol Rev"},{"key":"3071_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/ars.2009.2956","volume":"12","author":"SK Jain","year":"2010","unstructured":"Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, Bocchini JA (2010) Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12:1333\u20131337. https:\/\/doi.org\/10.1089\/ars.2009.2956","journal-title":"Antioxid Redox Signal"},{"key":"3071_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s00125-010-1761-5","volume":"53","author":"M Whiteman","year":"2010","unstructured":"Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, Shore AC (2010) Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 53:1722\u20131726. https:\/\/doi.org\/10.1007\/s00125-010-1761-5","journal-title":"Diabetologia"},{"key":"3071_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cca.2015.03.027","volume":"445","author":"B Olas","year":"2015","unstructured":"Olas B (2015) Gasomediators (\u00b7NO, CO, and H\u2082S) and their role in hemostasis and thrombosis. Clin Chim Acta 445:115\u2013121. https:\/\/doi.org\/10.1016\/j.cca.2015.03.027","journal-title":"Clin Chim Acta"},{"key":"3071_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.clinbiochem.2012.08.025","volume":"45","author":"A Morel","year":"2012","unstructured":"Morel A, Malinowska J, Olas B (2012) Antioxidative properties of hydrogen sulfide may involve in its antiadhesive action on blood platelets. Clin Biochem 45:1678\u20131682. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.08.025","journal-title":"Clin Biochem"},{"key":"3071_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/09537104.2016.1235693","volume":"28","author":"E Grambow","year":"2017","unstructured":"Grambow E, Leppin C, Leppin K, Kundt G, Klar E, Frank M, Vollmar B (2017) The effects of hydrogen sulfide on platelet-leukocyte aggregation and microvascular thrombolysis. Platelets 28:509\u2013517. https:\/\/doi.org\/10.1080\/09537104.2016.1235693","journal-title":"Platelets"},{"key":"3071_CR12","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1073\/pnas.1309049110","volume":"110","author":"R Bianca","year":"2013","unstructured":"d\u2019Emmanuele di Villa, Bianca R, Mitidieri E, Di Minno MND, Kirkby NS, Warner TD, Di Minno G, Cirino G, Sorrentino R (2013) Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. Proc Natl Acad Sci U S A 110:15812\u201315817. https:\/\/doi.org\/10.1073\/pnas.1309049110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3071_CR13","doi-asserted-by":"publisher","first-page":"e2101984","DOI":"10.1002\/adhm.202101984","volume":"11","author":"H Ding","year":"2022","unstructured":"Ding H, Chang J, He F, Gai S, Yang P (2022) Hydrogen sulfide: an emerging Precision Strategy for Gas Therapy. Adv Healthc Mater 11:e2101984. https:\/\/doi.org\/10.1002\/adhm.202101984","journal-title":"Adv Healthc Mater"},{"key":"3071_CR14","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA (2023) On behalf of the American Diabetes A. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care 46:S19\u2013S40. https:\/\/doi.org\/10.2337\/dc23-S002","journal-title":"Diabetes Care"},{"key":"3071_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11239-017-1573-2","volume":"45","author":"L Li","year":"2018","unstructured":"Li L, Qu C, Wu X, Dai J, Lu Y, Gong Y, You R, Liu Y (2018) Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus. J Thromb Thrombolysis 45:56\u201365. https:\/\/doi.org\/10.1007\/s11239-017-1573-2","journal-title":"J Thromb Thrombolysis"},{"key":"3071_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.niox.2015.01.004","volume":"46","author":"P Huang","year":"2015","unstructured":"Huang P, Chen S, Wang Y, Liu J, Yao Q, Huang Y, Li H, Zhu M, Wang S, Li L, Tang C, Tao Y, Yang G, Du J, Jin H (2015) Down-regulated CBS\/H2S pathway is involved in high-salt-induced hypertension in Dahl rats. Nitric Oxide 46:192\u2013203. https:\/\/doi.org\/10.1016\/j.niox.2015.01.004","journal-title":"Nitric Oxide"},{"key":"3071_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MBC.0000000000000826","volume":"30","author":"L Li","year":"2019","unstructured":"Li L, Qu C, Lu Y, Gong Y, You R, Miao L, Guo S (2019) The platelet surface glycosylation caused by glycosidase has a strong impact on platelet function. Blood Coagul Fibrinolysis 30:217\u2013223. https:\/\/doi.org\/10.1097\/MBC.0000000000000826","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3071_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41467-018-03430-6","volume":"9","author":"L Ju","year":"2018","unstructured":"Ju L, McFadyen JD, Al-Daher S, Alwis I, Chen Y, T\u00f8nnesen LL, Maiocchi S, Coulter B, Calkin AC, Felner EI, Cohen N, Yuan Y, Schoenwaelder SM, Cooper ME, Zhu C, Jackson SP (2018) Compression force sensing regulates integrin \u03b1\u03b2 adhesive function on diabetic platelets. Nat Commun 9:1087. https:\/\/doi.org\/10.1038\/s41467-018-03430-6","journal-title":"Nat Commun"},{"key":"3071_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.116.023835","volume":"134","author":"RF Storey","year":"2016","unstructured":"Storey RF, Parker WAE (2016) Choices for potent platelet inhibition in patients with diabetes Mellitus. Circulation 134:793\u2013796. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023835","journal-title":"Circulation"},{"key":"3071_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","volume":"16","author":"G Patti","year":"2019","unstructured":"Patti G, Cavallari I, Andreotti F, Calabr\u00f2 P, Cirillo P, Denas G, Galli M, Golia E, Maddaloni E, Marcucci R, Parato VM, Pengo V, Prisco D, Ricottini E, Renda G, Santilli F, Simeone P, De Caterina R (2019) Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs. Nat Rev Cardiol 16:113\u2013130. https:\/\/doi.org\/10.1038\/s41569-018-0080-2","journal-title":"Nat Rev Cardiol"},{"key":"3071_CR21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/hc3801.095588","volume":"104","author":"AD Michelson","year":"2001","unstructured":"Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533\u20131537","journal-title":"Circulation"},{"key":"3071_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/biology11020224","volume":"11","author":"K Pluta","year":"2022","unstructured":"Pluta K, Por\u0119bska K, Urbanowicz T, G\u0105secka A, Olasi\u0144ska-Wi\u015bniewska A, Targo\u0144ski R, Krasi\u0144ska A, Filipiak KJ, Jemielity M, Krasi\u0144ski Z (2022) Platelet-leucocyte aggregates as novel biomarkers in Cardiovascular diseases. Biology (Basel) 11:224. https:\/\/doi.org\/10.3390\/biology11020224","journal-title":"Biology (Basel)"},{"key":"3071_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1556\/IMAS.4.2012.4.2","volume":"4","author":"Z Patk\u00f3","year":"2012","unstructured":"Patk\u00f3 Z, Cs\u00e1sz\u00e1r A, Acs\u00e1dy G, Ory I, Tak\u00e1cs E, F\u0171r\u00e9sz J (2012) Elevation of monocyte-platelet aggregates is an early marker of type 2 diabetes. Interv Med Appl Sci 4:181\u2013185. https:\/\/doi.org\/10.1556\/IMAS.4.2012.4.2","journal-title":"Interv Med Appl Sci"},{"key":"3071_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.thromres.2007.07.016","volume":"121","author":"I Elalamy","year":"2008","unstructured":"Elalamy I, Chakroun T, Gerotziafas GT, Petropoulou A, Robert F, Karroum A, Elgrably F, Samama MM, Hatmi M (2008) Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res 121:843\u2013848","journal-title":"Thromb Res"},{"key":"3071_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2018.12.029","volume":"282","author":"N Allen","year":"2019","unstructured":"Allen N, Barrett TJ, Guo Y, Nardi M, Ramkhelawon B, Rockman CB, Hochman JS, Berger JS (2019) Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease. Atherosclerosis 282:11\u201318. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.029","journal-title":"Atherosclerosis"},{"key":"3071_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.thromres.2003.08.026","volume":"111","author":"N Li","year":"2003","unstructured":"Li N, Hu H, Hjemdahl P (2003) Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res 111:165\u2013170","journal-title":"Thromb Res"},{"key":"3071_CR27","first-page":"BR294","volume":"14","author":"T Schuerholz","year":"2008","unstructured":"Schuerholz T, L\u00f6sche W, Keil O, Friedrich L, Simon T-P, Marx G (2008) Acute short-term hyperglycemia impairs platelet receptor expression even in healthy adults in vitro. Med Sci Monit 14:BR294\u2013BR8","journal-title":"Med Sci Monit"},{"key":"3071_CR28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2003.08.033","volume":"92","author":"FK Keating","year":"2003","unstructured":"Keating FK, Sobel BE, Schneider DJ (2003) Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 92:1362\u20131365","journal-title":"Am J Cardiol"},{"key":"3071_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2141.2006.06012.x","volume":"133","author":"D Sudic","year":"2006","unstructured":"Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N (2006) High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Haematol 133:315\u2013322","journal-title":"Br J Haematol"},{"key":"3071_CR30","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1172\/JCI59291","volume":"121","author":"WH Tang","year":"2011","unstructured":"Tang WH, Stitham J, Gleim S, Di Febbo C, Porreca E, Fava C, Tacconelli S, Capone M, Evangelista V, Levantesi G, Wen L, Martin K, Minuz P, Rade J, Patrignani P, Hwa J (2011) Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J Clin Invest 121:4462\u20134476. https:\/\/doi.org\/10.1172\/JCI59291","journal-title":"J Clin Invest"},{"key":"3071_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2003.10.055","volume":"484","author":"JP De La Cruz","year":"2004","unstructured":"De La Cruz JP, Arrebola MM, Villalobos MA, Pinacho A, Guerrero A, Gonz\u00e1lez-Correa JA, S\u00e1nchez de la Cuesta F (2004) Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction. Eur J Pharmacol 484:19\u201327. https:\/\/doi.org\/10.1016\/j.ejphar.2003.10.055","journal-title":"Eur J Pharmacol"},{"key":"3071_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2169\/internalmedicine.56.7403","volume":"56","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Sagara M, Aoki C, Tanaka S, Aso Y (2017) Clinical implication of plasma hydrogen sulfide levels in Japanese patients with type 2 diabetes. Intern Med 56:17\u201321. https:\/\/doi.org\/10.2169\/internalmedicine.56.7403","journal-title":"Intern Med"},{"key":"3071_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/FJC.0000000000000142","volume":"64","author":"L Zhong","year":"2014","unstructured":"Zhong L, Lv L, Yang J, Liao X, Yu J, Wang R, Zhou P (2014) Inhibitory effect of hydrogen sulfide on platelet aggregation and the underlying mechanisms. J Cardiovasc Pharmacol 64:481\u2013487. https:\/\/doi.org\/10.1097\/FJC.0000000000000142","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:50:43Z","timestamp":1745038243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["3071"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03071-9","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"17 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}